AGED:SW:SW-iShares Ageing Population UCITS ETF USD (Acc) (USD)

ETF | Others |

Last Closing

USD 7.099

Change

-0.10 (-1.32)%

Market Cap

N/A

Volume

2.20K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
CHSRIA:SW UBS ETF (CH) MSCI Switzerland ..

-0.04 (-0.20%)

USD 492,935.36B
XLDX:SW Xtrackers LevDAX Daily Swap UC..

-1.12 (-0.69%)

USD 411,075.38B
CHSRI:SW UBS ETF (CH) - MSCI Switzerlan..

-0.02 (-0.12%)

USD 368,190.74B
XNIF:SW Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
SWICHA:SW UBS ETF (CH) – MSCI Switzerl..

+0.01 (+0.05%)

USD 226,274.25B
SWUSAH:SW UBS ETF (CH) – MSCI Switzerl..

+0.01 (+0.02%)

USD 226,274.21B
SWEUAH:SW UBS ETF (CH) – MSCI Switzerl..

N/A

USD 226,274.20B
RGLDS:SW Raiffeisen ETF Solid Gold A US..

N/A

USD 134,034.93B
RGLDSH:SW Raiffeisen ETF Solid Gold H CH..

+1.50 (+0.03%)

USD 134,034.91B
RGLDOH:SW Raiffeisen ETF Solid Gold Ounc..

+18.60 (+1.26%)

USD 134,034.86B

ETFs Containing AGED:SW

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.63% 28% F 31% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.63% 27% F 30% F
Trailing 12 Months  
Capital Gain 4.40% 40% F 43% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.40% 40% F 43% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.19% 48% F 49% F
Dividend Return 2.19% 48% F 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 4.02% 69% C- 73% C
Risk Adjusted Return 54.50% 53% F 57% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.